Actively Recruiting
Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery
Led by Laboratoires Thea · Updated on 2026-05-04
30
Participants Needed
1
Research Sites
58 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this non-interventional, open and monocentric study is to evaluate the satisfaction of 30 patients, after 3 months with Blephaderm eyelid cream, as a complementary care in post-eyelid surgery (Blepharopasty or ptosis). The participant will be asked to use Blephaderm twice a day. The patient satisfaction will be evaluated using a VAS scale.
CONDITIONS
Official Title
Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 69 18 years old
- Patients planning a blepharoplasty or a ptosis surgery in at least one eye
- Patient affiliated to a health social security system
- Female of childbearing potential should use a medically accepted contraceptive regimen since at least 12 weeks before the beginning of the study, during all the study and at least 1 month after the study end
You will not qualify if you...
- Pregnant or nursing woman or planning a pregnancy during the study
- Patient who had been deprived of their freedom by administrative or legal decision
- Minor patient
- Major patient who is under guardianship or who is not able to express his non opposition
- Patient suspected to be non-compliant according to the investigator's judgment
- Patient enrolled in another clinical trial or which exclusion period is not over
- Patient with a history or active systemic condition or receiving a medication which, in the investigator's judgment, put the patient at undue risk
- Patient suffering from a severe or progressive disease
- Patient with known or suspected hypersensitivity to one of the components of the product
- Patient undergoing a topical treatment on the test area or a systemic treatment
- Patient under a long-term corticosteroid, NSAID or HIV therapy at the investigator appreciation
- Patient under immunosuppressive therapy
- Patient under bisphosphonate therapy
- Patient having Type 1 diabetes
- Patient having atopic or eczema skin
- Intensive exposure to sunlight or UV-rays foreseen during the study
- Patient planning to change her/his life habits during the study
- Patient with an excessive consumption of alcohol and/or tobacco defined as:
- an excessive consumption of alcohol: Drinking more than
- 4 units a day for adult men and more than 2 units a day for adult women,
- an excessive consumption of tobacco: 6915-20 Cigarettes Per Day (CPD)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pierre-Vincent Jacomet Private Practice
Paris, France
Actively Recruiting
Research Team
M
Medical Affairs Director
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here